CoChat

HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity

Open access
Liu, Jianuo, Xu, Peng, Collins, Cory, Liu, Han, Zhang, Jingdong, Keblesh, James P., Xiong, Huangui · 2013 · PLoS ONE
Cited by 28

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Microglia plays a crucial role in the pathogenesis of HIV-1-associated neurocognitive disorders. Increasing evidence indicates the voltage-gated potassium (Kv) channels are involved in the regulation of microglia function, prompting us to hypothesize Kv channels may also be involved in microglia-mediated neurotoxic activity in HIV-1-infected brain. To test this hypothesis, we investigated the involvement of Kv channels in the response of microglia to HIV-1 Tat protein. Treatment of rat microglia with HIV-1 Tat protein (200 ng/ml) resulted in pro-inflammatory microglial activation, as indicated by increases in TNF-α, IL-1β, reactive oxygen species, and nitric oxide, which were accompanied by enhanced outward K(+) current and Kv1.3 channel expression. Suppression of microglial Kv1.3 channel activity, either with Kv1.3 channel blockers Margatoxin, 5-(4-Phenoxybutoxy)psoralen, or broad-spectrum K(+) channel blocker 4-Aminopyridine, or by knockdown of Kv1.3 expression via transfection of microglia with Kv1.3 siRNA, was found to abrogate the neurotoxic activity of microglia resulting from HIV-1 Tat exposure. Furthermore, HIV-1 Tat-induced neuronal apoptosis was attenuated with the application of supernatant collected from K(+) channel blocker-treated microglia. Lastly, the intracellular signaling pathways associated with Kv1.3 were investigated and enhancement of microglial Kv1.3 was found to correspond with an increase in Erk1/2 mitogen-activated protein kinase activation. These data suggest targeting microglial Kv1.3 channels may be a potential new avenue of therapy for inflammation-mediated neurological disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0064904

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 53

  1. M Kaul, 2006, Mechanisms of neuronal injury and death in HIV-1 associated dementia, Curr HIV Res, 4, 307, 10.2174/157016206777709384 · DOI · Paper page
  2. KR Robertson, 2007, The prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, 21, 1915, 10.1097/QAD.0b013e32828e4e27 · DOI · Paper page
  3. SS Spudich, 2011, Central nervous system complications of HIV infection, Top Antivir Med, 19, 48
  4. JD Glass, 1995, Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia, Ann Neurol, 38, 755, 10.1002/ana.410380510 · DOI · Paper page
  5. Gendelman HE, Eiden L, Epstein L, Grant I, Lipton S, <etal>et al</etal>.. (1998) The Neuropathogenesis of HIV-1-Dementia: APanel Discussion. In: Gendelman HE, Lipton SA, Epstein LG, Swindells S, editors. The neurology of AIDS. 1 ed. New York: Chapman and Hall. pp. 1–10.
  6. GA Garden, 2002, Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, 40, 240, 10.1002/glia.10155 · DOI · Paper page
  7. T Kielian, 2004, Microglia and chemokines in infectious diseases of the nervous system: views and reviews, Front Biosci, 9, 732, 10.2741/1266 · DOI
  8. H Kettenmann, 2011, Physiology of microglia, Physiol Rev, 91, 461, 10.1152/physrev.00011.2010 · DOI · Paper page
  9. A Wickenden, 2002, K(+) channels as therapeutic drug targets, Pharmacol Ther, 94, 157, 10.1016/S0163-7258(02)00201-2 · DOI · Paper page
  10. SI Judge, 2006, Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration, J Rehabil Res Dev, 43, 111, 10.1682/JRRD.2004.09.0116 · DOI
  11. W Norenberg, 1994, Voltage-dependent potassium channels in activated rat microglia, J Physiol, 475, 15, 10.1113/jphysiol.1994.sp020046 · DOI · Paper page
  12. HG Fischer, 1995, Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states, Neuroscience, 64, 183, 10.1016/0306-4522(94)00398-O · DOI
  13. C Eder, 1998, Ion channels in microglia (brain macrophages), Am J Physiol, 275, C327, 10.1152/ajpcell.1998.275.2.C327 · DOI · Paper page
  14. T Schilling, 2000, Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta, Am J Physiol Cell Physiol, 279, C1123, 10.1152/ajpcell.2000.279.4.C1123 · DOI · Paper page
  15. H Kettenmann, 1990, Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages, J Neurosci Res, 26, 278, 10.1002/jnr.490260303 · DOI · Paper page
  16. C Eder, 1999, Morphological, immunophenotypical and electrophysiological properties of resting microglia in vitro, Eur J Neurosci, 11, 4251, 10.1046/j.1460-9568.1999.00852.x · DOI · Paper page
  17. W Walz, 2001, Ion channels in cultured microglia, Microsc Res Tech, 54, 26, 10.1002/jemt.1117 · DOI
  18. K Farber, 2005, Physiology of microglial cells, Brain Res Brain Res Rev, 48, 133, 10.1016/j.brainresrev.2004.12.003 · DOI · Paper page
  19. HE Gendelman, 2009, Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration, J Neuroimmune Pharmacol, 4, 47, 10.1007/s11481-008-9135-1 · DOI · Paper page
  20. N Nutile-McMenemy, 2007, Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression, J Neurochem, 103, 2035, 10.1111/j.1471-4159.2007.04889.x · DOI · Paper page
  21. C Xu, 2011, HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia, Glia, 59, 997, 10.1002/glia.21171 · DOI
  22. MO Westendorp, 1995, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature, 375, 497, 10.1038/375497a0 · DOI · Paper page
  23. H Xiao, 2000, Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1, Proc Natl Acad Sci U S A, 97, 11466, 10.1073/pnas.97.21.11466 · DOI · Paper page
  24. R Bonavia, 2001, HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons, Biochem Biophys Res Commun, 288, 301, 10.1006/bbrc.2001.5743 · DOI
  25. K Hayashi, 2006, HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier, J Cereb Blood Flow Metab, 26, 1052, 10.1038/sj.jcbfm.9600254 · DOI
  26. M Koistinaho, 2002, Role of p38 and p44/42 mitogen-activated protein kinases in microglia, Glia, 40, 175, 10.1002/glia.10151 · DOI · Paper page
  27. M Strniskova, 2002, Mitogen-activated protein kinases and their role in regulation of cellular processes, Gen Physiol Biophys, 21, 231
  28. B Kaminska, 2009, MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target, Anat Rec (Hoboken), 292, 1902, 10.1002/ar.21047 · DOI · Paper page
  29. S Koenig, 1986, Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science, 233, 1089, 10.1126/science.3016903 · DOI · Paper page
  30. P Genis, 1992, Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease, J Exp Med, 176, 1703, 10.1084/jem.176.6.1703 · DOI · Paper page
  31. M Kaul, 2001, Pathways to neuronal injury and apoptosis in HIV-associated dementia, Nature, 410, 988, 10.1038/35073667 · DOI · Paper page
  32. A Menteyne, 2009, Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus, PLoS One, 4, e6770, 10.1371/journal.pone.0006770 · DOI · Paper page
  33. AA Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, 403, 503, 10.1038/35000501 · DOI · Paper page
  34. M Abdul, 2003, Activity of potassium channel-blockers in breast cancer, Anticancer Res, 23, 3347
  35. M Brevet, 2008, Expression of K+ channels in normal and cancerous human breast, Histol Histopathol, 23, 965
  36. S Kramer-Hammerle, 2005, Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus, Virus Res, 111, 194, 10.1016/j.virusres.2005.04.009 · DOI · Paper page
  37. SU Kim, 2005, Microglia in health and disease, J Neurosci Res, 81, 302, 10.1002/jnr.20562 · DOI · Paper page
  38. ST Dheen, 2007, Microglial activation and its implications in the brain diseases, Curr Med Chem, 14, 1189, 10.2174/092986707780597961 · DOI · Paper page
  39. YB Lee, 2000, p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms, Cytokine, 12, 874, 10.1006/cyto.2000.0688 · DOI
  40. JR Lokensgard, 2001, Diazepam inhibits HIV-1 Tat-induced migration of human microglia, J Neurovirol, 7, 481, 10.1080/135502801753170345 · DOI
  41. EA Eugenin, 2005, HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS, Glia, 49, 501, 10.1002/glia.20137 · DOI · Paper page
  42. S Visentin, 2001, Altered outward-rectifying K(+) current reveals microglial activation induced by HIV-1 Tat protein, Glia, 33, 181, 10.1002/1098-1136(200103)33:3<181::AID-GLIA1017>3.0.CO;2-Q · DOI
  43. JP Keblesh, 2009, 4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis, J Neuroimmune Pharmacol, 4, 317, 10.1007/s11481-009-9161-7 · DOI
  44. KG Chandy, 2004, K+ channels as targets for specific immunomodulation, Trends Pharmacol Sci, 25, 280, 10.1016/j.tips.2004.03.010 · DOI · Paper page
  45. C Beeton, 2006, Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases, Proc Natl Acad Sci U S A, 103, 17414, 10.1073/pnas.0605136103 · DOI · Paper page
  46. KG Chandy, 1984, Voltage-gated potassium channels are required for human T lymphocyte activation, J Exp Med, 160, 369, 10.1084/jem.160.2.369 · DOI · Paper page
  47. H Wulff, 2003, Potassium channels as therapeutic targets for autoimmune disorders, Curr Opin Drug Discov Devel, 6, 640
  48. H Wulff, 2003, The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS, J Clin Invest, 111, 1703, 10.1172/JCI16921 · DOI · Paper page
  49. R Vianna-Jorge, 2004, Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?, BioDrugs, 18, 329, 10.2165/00063030-200418050-00005 · DOI
  50. C Beeton, 2011, Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases, Inflamm Allergy Drug Targets, 10, 313, 10.2174/187152811797200641 · DOI
  51. P Valverde, 2005, Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease, J Dent Res, 84, 488, 10.1177/154405910508400603 · DOI
  52. B Goffe, 2005, An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy, Clin Ther, 27, 1912, 10.1016/j.clinthera.2005.12.007 · DOI
  53. F Esamai, 2005, A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria, J Trop Pediatr, 51, 17, 10.1093/tropej/fmh069 · DOI

Cited by

See all 28

Metadata

Authors
Liu, J., Xu, P., Collins, C., Liu, H., Zhang, J., Keblesh, J. P., & Xiong, H.
Venue
PLoS ONE
Published
2013-05-30
Volume
8
Issue
5
Pages
e64904
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1967851503
Cited by
28
References
8
FWCI
1.77
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity. https://app.cochat.ai/papers/10.1371/journal.pone.0064904
The paper
Liu, J., Xu, P., Collins, C., Liu, H., Zhang, J., Keblesh, J. P., & Xiong, H. (2013). HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity. PLoS ONE. https://doi.org/10.1371/journal.pone.0064904

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.